Amazon is reportedly mulling on expanding its business in Japan and entering the prescription drug market there. The e-commerce and tech firm is said to be planning to team up with small to mid-sized pharmacies for the project.
According to Nikkei Asia, some sources who are familiar with the project shared that Amazon may launch a new prescription service through partnerships with the local pharmacies in the Asian nation. They added that this is likely to be established starting next year when electronic prescriptions are set to be allowed in Japan for the first time.
The sources opined that if Amazon pushes through with this plan of jumping into the prescription drug sales business, this move could be a turning point for the local brick-and-mortar pharmacies in Japan.
This is because, with the application of Amazon’s cutting-edge ordering and distribution system, customers in the country will be able to have their medicines delivered right on the steps of their homes instead of going out to buy them in pharmacy stores.
To operate the business, Amazon will join forces with local pharmacies and set up a platform where patients can find instructions online - on how to take their medications. In any case, the prices of prescription drugs in Japan are usually set by the government, while the distribution system is in shambles since there are 70 wholesalers across the country, and the number of pharmacies has already reached 60,000.
Thus, if Amazon will enter the country’s prescription drug market, it will be able to offer a more organized distribution system as well. This means that patients and consumers will be able to receive their medicines in a timely and orderly manner.
Meanwhile, Fox Business further reported that the new prescription service may be launched next year and through Amazon, pharmacies in Japan will be able to sell medicines directly to patients online since Japan will start allowing electronic prescriptions in the country by that time. People may obtain virtual prescriptions on Amazon’s platform after receiving professional medical care online.


U.S. Dollar Slips Near Two-Month Low as Markets Await Key Jobs Data and Central Bank Decisions
Bank of Korea Downplays Liquidity’s Role in Weak Won and Housing Price Surge
Bank of Japan Poised for Historic Rate Hike as Inflation Pressures Persist
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit
Coca-Cola’s Proposed Sale of Costa Coffee Faces Uncertainty Amid Price Dispute
Australian Consumer Sentiment Slumps in Early December as Inflation Fears Resurface
Dollar Struggles as Markets Eye Key Central Bank Decisions and Global Rate Outlooks
Gold Prices Slip Slightly in Asia as Silver Nears Record Highs on Dovish Fed Outlook
SpaceX Begins IPO Preparations as Wall Street Banks Line Up for Advisory Roles
Trello Outage Disrupts Users as Access Issues Hit Atlassian’s Work Management Platform
HSBC’s $13.6 Billion Take-Private Offer for Hang Seng Bank Gains Board Backing
Asian Technology and Chipmaking Stocks Slide as AI Spending Concerns Shake Markets
Japan PMI Data Signals Manufacturing Stabilization as Services Continue to Drive Growth
Nomura Expands Alternative Assets Strategy With Focus on Private Debt Acquisitions
Korea Zinc Plans $6.78 Billion U.S. Smelter Investment With Government Partnership
Fortescue Expands Copper Portfolio With Full Takeover of Alta Copper
Trump Sues BBC for Defamation Over Edited Capitol Riot Speech Clip 



